You are here

Subscribe

Donors Your Gifts at Work

All
All

We invite you to share your story to help raise awareness. If you have been or are being treated for cancer at Duke or if you are a caregiver, we'd like to know how cancer care, research or clinical trials at Duke has affected your life. Are you a donor? If so, please consider sharing you story. Tell us why you choose to team up with Duke Cancer Institute. For more information or to share your story, please contact Sara Wajda, Director of Annual Giving, DCI Development.

Greater Exposure To Flame Retardants May Be Associated With Thyroid Cancer

Higher exposure to chemicals used to reduce the flammability of furniture, carpets, electronics and other household items appears to be associated with papillary thyroid cancer, according to study conducted by the Duke Cancer Institute and the Nicholas School of the Environment at Duke University...

Study Shows How BPA May Affect Inflammatory Breast Cancer

The chemical bisphenol A, or BPA, appears to aid the survival of inflammatory breast cancer cells, revealing a potential mechanism for how the disease grows, according to a study led by researchers in the Department of Surgery at Duke University School of Medicine and the Duke Cancer Institute ...

Genetic Study Identifies 12 New Variants For Ovarian Cancer

A genetic examination of the DNA of almost 100,00 people, including 17,000 patients with the most common type of ovarian cancer, has identified 12 new genetic variants that increase risk of developing the disease and confirmed the association of 18 of the previously published variants. Published...

New Comprehensive Guide on Thyroid Nodules and Cancer

According to Sanziana Roman, MD , and Julie Ann Sosa, MD , Division of Advanced Oncologic and Gastrointestinal Surgery, thyroid nodules continue to be a common problem worldwide. Though many nodules are benign, anxiety on the part of both the physician and patient can cause unnecessary...

Reducing Radiation May Cut Breast Cancer Treatment Costs

More than half of older women with early stage breast cancer received more radiation therapy than what might be medically necessary, adding additional treatment and health care costs, according to a study led by Duke Cancer Institute researchers. The researchers found that the annual estimated cost...

Duke Researchers Reveal Genetic Causes of Rare, But Lethal HSTL

Led by a team from Duke, an international group of 56 researchers has found new mutations identifying potential treatments and new hope for patients with hepatosplenic T cell lymphoma (HSTL or HSCTL) — one of the deadliest cancers known. Through whole exome sequencing of 68 human tissue samples...

New Tools In The Battle Against Bile Duct Cancer

Often by the time bile duct cancer is diagnosed, it’s already metastasized. Highly aggressive, bile duct cancer usually comes with limited treatment options and a poor prognosis. Because it’s a relatively rare cancer — only about 8,000 cases are diagnosed each year — additional therapies have not...

Enlisting A Dog In The Fight Against Cancer

For years, dogs have sniffed-out land mines, rescued earthquake victims, and guided the blind. Today our BFFs are teaming up with us to confront a shared formidable foe — cancer. America’s 83 million pet dogs share our environment, have similar genomes and develop spontaneous tumors much like we do...

Neuro-Onc Faculty Spotlight: Dina Randazzo, DO

Dina Randazzo, DO, was 13 when she was told that her father had less than three months to live. This event inspired her to become a neuro-oncologist, both to help people with brain tumors and to provide compassion and honesty to patients and their loved ones. In this interview, Randazzo talks to us...

Pages